Companies › ROIV

ROIVANT SCIENCES LTD (ROIV)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001635088 · EDGAR filings · Updated 2026-07-27

ROIVANT SCIENCES LTD (ROIV) has reported institutional ownership of 73.7%, with 437 institutional managers holding positions valued at $14.7B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-27 — Notice of proposed sale filed (Form 144)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Insider transaction reported (Form 4)
• 2026-07-21 — Insider transaction reported (Form 4)
• 2026-07-21 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ROIVANT SCIENCES LTD has 437 institutional holders and institutional ownership of 73.7%.

Insider activity

Insiders reported 231 transactions (1 buys, 97 sells) across 14 reporting insiders, with a net reported value of −$723.8M.

Related companies

ROYALTY PHARMA PLC CLASS A (RPRX) · MODERNA INC (MRNA) · TENET HEALTHCARE CORP (THC) · COOPER COS INC (COO) · INSULET CORP (PODD) · BRIDGEBIO PHARMA INC (BBIO)